We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
-10.7%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$11.7B
AUM Growth
-$3.17B
Cap. Flow
-$1.15B
Cap. Flow %
-9.88%
Top 10 Hldgs %
46.25%
Holding
136
New
17
Increased
36
Reduced
23
Closed
34

Top Buys

Rank Stock Value
1
CNC icon
Centene
CNC
+$440M
2
IQV icon
IQVIA
IQV
+$269M
3
AGN
Allergan plc
AGN
+$247M
4
GD icon
General Dynamics
GD
+$183M
5
FIS icon
Fidelity National Information Services
FIS
+$158M

Top Sells

Rank Stock Value
1
WCG
Wellcare Health Plans, Inc.
WCG
+$793M
2
MDCO
Medicines Co
MDCO
+$282M
3
ZAYO
Zayo Group Holdings, Inc.
ZAYO
+$236M
4
SPGI icon
S&P Global
SPGI
+$175M
5
MYOK
MyoKardia, Inc. Common Stock
MYOK
+$104M

Sector Composition

Rank Sector Weight
1 Healthcare 52.14%
2 Communication Services 12.39%
3 Technology 10.92%
4 Industrials 5.44%
5 Financials 3.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QTNT
76
DELISTED
Quotient Limited Ordinary Shares
QTNT
$9.88M 0.08%
62,500
– –
VSTM icon
77
Verastem
VSTM
$624M
$9.82M 0.08%
+310,078
New +$7.78M
AKBA icon
78
Akebia Therapeutics
AKBA
$251M
$9.47M 0.08%
+1,250,000
New +$9.72M
PACB icon
79
Pacific Biosciences
PACB
$420M
$9.18M 0.08%
3,000,000
– –
RC
80
Ready Capital
RC
$311M
$9.15M 0.08%
1,267,896
-349,274
-22% -$4.78M
CYTK icon
81
Cytokinetics
CYTK
$10.7B
$7.37M 0.06%
+625,000
New +$7.97M
DMTK
82
DELISTED
DermTech, Inc. Common Stock
DMTK
$6.81M 0.06%
605,255
-10,130
-2% -$124K
ADSW
83
DELISTED
Advanced Disposal Services Inc
ADSW
$5.79M 0.05%
+176,610
New +$5.79M
OPTN
84
DELISTED
OptiNose
OPTN
$3.5M 0.03%
52,032
-7,968
-13% -$803K
BEAM icon
85
Beam Therapeutics
BEAM
$3.07B
$3.06M 0.03%
+170,164
New +$3.7M
XRX icon
86
Xerox
XRX
$381M
$2.46M 0.02%
130,000
– –
AGTC
87
DELISTED
Applied Genetic Technologies Corporation
AGTC
$1.92M 0.02%
+586,497
New +$3.09M
BRMK.WS
88
DELISTED
Broadmark Realty Capital Inc. Warrants, each exercisable for one fourth (1/4th) share of Common Stock at an exercise price of $2.875 per quarter share
BRMK.WS
$1.58M 0.01%
7,174,613
– –
GOSS icon
89
Gossamer Bio
GOSS
$75.6M
$1.01M 0.01%
100,000
-400,000
-80% -$5.22M
RVMD icon
90
Revolution Medicines
RVMD
$44.9B
$454K ﹤0.01%
+20,733
New +$574K
GOL
91
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
$367K ﹤0.01%
+85,838
New +$1.09M
EIGR
92
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$341K ﹤0.01%
1,670
-34,815
-95% -$11.1M
PHAS
93
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$280K ﹤0.01%
84,502
-915,498
-92% -$4.19M
ABEO icon
94
Abeona Therapeutics
ABEO
$348M
– –
-80,000
Closed -$6.54M
AMRN
95
CALL
Amarin Corp
AMRN
$298M
– –
-50,000
Closed -$21.4M
AXSM icon
96
Axsome Therapeutics
AXSM
$10.9B
– –
-442,222
Closed -$45.7M
CVS icon
97
CVS Health
CVS
$119B
– –
-750,000
Closed -$55.7M
CYCN icon
98
Cyclerion Therapeutics
CYCN
$18.2M
– –
-17,500
Closed -$952K
GEN icon
99
Gen Digital
GEN
$17.3B
– –
-720,000
Closed -$18.4M
HRTX icon
100
Heron Therapeutics
HRTX
$60.4M
– –
-875,000
Closed -$20.6M
2 3
4
5 6

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q1 2020 Portfolio in Review

As of Q1 2020, Thomas Steyer held 136 positions worth $11.7B, down 21% from $14.8B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Thomas Steyer withdrew a net $1.15B in Q1 2020, closing 34 positions and reducing 23 holdings. Its most notable exit was Wellcare Health Plans, Inc., an estimated $793M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, up from 47% a quarter earlier, followed by Communication Services and Technology.

Against the trend, Thomas Steyer opened a new position in Centene worth $431M.

  • Thomas Steyer's largest Q1 2020 buy was Centene: 7,250,000 shares worth $431M.
  • Thomas Steyer added most to IQVIA in Q1 2020, an estimated $269M increase.
  • Thomas Steyer's biggest Q1 2020 reduction was MyoKardia, Inc. Common Stock, cutting an estimated $104M.
  • Thomas Steyer fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $793M.
  • Thomas Steyer's ten largest holdings make up 46% of its $11.7B portfolio in Q1 2020.
  • Thomas Steyer opened 17 new positions and closed 34 in Q1 2020.
  • Thomas Steyer's portfolio value fell 21% quarter-over-quarter to $11.7B.

Based on Farallon Capital Management's 13F filing for Q1 2020, filed 15 May 2020.